IP Verse

Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor - EP3067043

PATENT ANALYSIS

Patent Details

Grant Date
Nov 30, 2022
Company
NOVARTIS AG
Oppositions

BULLE DR., JAN

DR. SCHON, NEYMEYR & PARTNER PATENTANWALTE MBB

GENERICS (UK) LTD

STADA ARZNEIMITTEL AG

TEVA PHARMACEUTICAL INDUSTRIES LTD.

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you